Abstract Details
<< Back to Instructional Sessions
10/08/2023 | 3:00 PM - 4:30 PM | 6613
CMV 101 The Basics and the Updates about Congenital CMV for 2023
Abstract Summary
The basics of congenital CMV will be reviewed, and significant updates for 2023 will be highlighted in this educational overview talk on CMV infection in pregnant persons and congenital CMV in newborns, and CMV in children as they grow. We will discuss CMV epidemiology, transmission, clinical presentations, diagnoses, newborn screening, treatments, prevention, awareness, and advocacy. This session gets you ready for the conference, by updating you on both CMV basics and CMV hot topics.
Learning Objectives
- Refresh our knowledge of the basics of CMV epidemiology, transmission, diagnosis, teatments and prevention
- Update our knowledge of the new updates concerning congenital CMV
- Understand the controversies and knowledge gaps in congenital CMV diagnosis, managemeent, and prevention
Presentation
This presentation has not yet been uploaded.
Handouts
No handouts have been uploaded.
Presenters
Gail Demmler-Harrison | Primary Presenter
gdemmler@bcm.edu;
Dr. Gail Demmler-Harrison is Professor of Pediatrics at Baylor College of Medicine, Attending Physician Infectious Diseases Service and CMV Clinic Lead at Texas Children’s Hospital, Houston, Texas. Her research, clinical experience, and expertise has focused for over 40 years on the epidemiology, diagnosis, treatment, prevention and long term outcomes of cytomegalovirus (CMV) infections in pregnant persons and their newborns. Her research has defined congenital CMV as a lifelong condition and helped change the standard of care for these children, including monitoring for sensorineural hearing loss progression and later onset hearing loss in children affected by congenital CMV. She has been instrumental in advocating for the passage of CMV education and CMV newborn screening laws, and CMV awareness.
She is the author or co-author of hundreds of scientific and educational publications, book chapters, on line videos, and has presented hundreds of invited lectures and original science presentations.
ASHA DISCLOSURE
Financial - Receives Royalty options or other ownership interest for Other activities from Elsevier. Receives Speaker for Teaching and speaking from Medscape WEBMD. Receives Consulting fee,Grants for Consulting,Independent contractor from Merck. Receives Consulting fee,Grants for Consulting,Independent contractor from Microgen Labs. Receives Consulting fee,Grants for Consulting,Independent contractor from Moderna. Receives Consulting fee,Honoraria excluding diversified mutual funds,Other financial benefit for Teaching and speaking,Consulting from WEBMD Medscape. Receives Royalty options or other ownership interest for Other activities from Wolters Kluwer UpToDate.
Nonfinancial - No relevant nonfinancial relationship exists.
AAA DISCLOSURE
Financial - Receives support from Moderna, Merck, Microgen Labs, Elsevier, Wolters/Kluwer, WEBMD Medscape for Research and spoken or written topics related to congenital infections, including congenital CMV, and neonatal infections, including neonatal HSV, and also pediatric infectious diseases in general; all activities are research/scholarly/educational and/or CME certified..